Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors
ConditionStroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21-90
SponsorTan Tock Seng Hospital
About this trial
As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions.
Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram)
First ever confirmed stroke
Asian ethnicity
Age 21-90 years
Disqualifiers
Recurrent stroke or transient ischaemic attack (TIA)
Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours
Bilateral upper limb impairment.
Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded.
Trial population
Patients admitted to inpatient rehabilitation unit
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Clinical and technological-aided assessments and questionnaires
Other interventionAssessments and questionnaires related to upper limb function and quality of life will be used
Treatment groups
400 Participants
are divided into 1 treatment groupGroup A: Intervention1 intervention
Trial outcomes
Primary outcomes
1
Fugl-Meyer Assessment (FMA)
The FMA-UE is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, in patients with post-stroke hemiplegia.
Time frame
Inpatient: week 1 of admissionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Tan Tock Seng Hospital
Lead sponsor
Rehabilitation Research Institute of Singapore (RRIS)
Collaborator
Singapore-ETH Centre (SEC)
Collaborator
Source ClinicalTrials.gov